Angela Declue
Family · Potosi, MONPI 1659343903
Payments from drug & device makers
Across 312 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lilly USA, LLC$454
- Amarin Pharma, Inc.$220
- GSK$202
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$176
- AstraZeneca$158
- plus $1K from 31 others
What the payments were for
- Food & beverage$5,765100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 149 | $3,177 |
| Lilly USA, LLC | 25 | $454 |
| Amarin Pharma, Inc. | 14 | $220 |
| GSK | 17 | $202 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $176 |
| AstraZeneca | 5 | $158 |
| Biohaven Pharmaceutical Holding Company Ltd. | 14 | $121 |
| Biohaven Pharmaceuticals, Inc. | 11 | $117 |
| Amgen | 7 | $106 |
| Novo Nordisk | 5 | $90 |
| Boehringer Ingelheim | 2 | $85 |
| Otsuka America Pharmaceutical, Inc. | 5 | $83 |
| Exact Sciences | 4 | $72 |
| Pfizer | 4 | $68 |
| Sunovion Pharmaceuticals Inc. | 4 | $60 |
| Intuitive Surgical | 2 | $58 |
| Novartis | 3 | $48 |
| Sumitomo Pharma America, Inc. | 4 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Boston Scientific | 2 | $31 |
| Merck | 2 | $28 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Tactile Systems Technology Inc | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Gilead | 1 | $21 |
| Bayer | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Nevro Corp. | 1 | $17 |
| Abbott | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Masimo Corporation | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Grifols USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$125
How this compares
$5,765 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 78 | $84,781 |
| MounjaroTirzepatide | 44 | $58,591 |
| TrulicityDulaglutide | 43 | $49,191 |
| JardianceEmpagliflozin | 62 | $47,122 |
| FarxigaDapagliflozin Propanediol | 58 | $34,965 |
| EliquisApixaban | 31 | $25,719 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $20,928 |
| Nurtec OdtRimegepant Sulfate | 15 | $19,042 |
| RexultiBrexpiprazole | 13 | $18,640 |
| VraylarCariprazine Hcl | 11 | $16,000 |
| SynjardyEmpagliflozin/Metformin Hcl | 17 | $15,374 |
| AptiomEslicarbazepine Acetate | 12 | $15,002 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 52 | $9,009 |
| Spiriva RespimatTiotropium Bromide | 14 | $7,556 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 61 | $7,218 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $454 | $107,78187 claims |
| Novo NordiskOzempic | $90 | $84,78178 claims |
| Boehringer IngelheimJardiance, Synjardy, Spiriva Respimat | $85 | $70,05293 claims |
| PfizerEliquis, Nurtec Odt | $68 | $44,76146 claims |
| AstraZenecaFarxiga | $158 | $34,96558 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta | $202 | $23,28342 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $83 | $18,64013 claims |
| AbbVieVraylar | $3,177 | $16,00011 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $60 | $15,00212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,812 family providers in Missouri.
Other family in Potosi
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.